SY trades 52.9% above Wall Street's consensus target of $0.80.
Last 12 months price action with 12-month analyst target path
The base valuation assumes SY achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, So-Young International Inc. (SY) has a Wall Street consensus price target of $0.80, based on estimates from 5 covering analysts. With the stock currently trading at $1.70, this represents a potential downside of -52.9%. The company has a market capitalization of $223M.
Analyst price targets range from a low of $0.80 to a high of $0.80, representing a 0% spread in expectations. The median target of $0.80 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 5 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, SY trades at a trailing P/E of -6.5x. Analysts expect EPS to grow +9.5% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
MTCHMatch Group, Inc. | $9.1B | $39.18 | $41.13 | +5.0% | Buy | 14.8x | 32 |
YELPYelp Inc. | $1.5B | $26.55 | $27.50 | +3.6% | Hold | 14.1x | 67 |
ANGIAngi Inc. | $258M | $6.44 | $11.60 | +80.1% | Hold | 22.9x | 54 |
DOCSDoximity, Inc. | $4.3B | $22.74 | $29.47 | +29.6% | Hold | 15.9x | 23 |
SKINThe Beauty Health Company | $144M | $1.11 | $1.53 | +37.8% | Hold | — | 14 |
INMDInMode Ltd. | $921M | $14.54 | $18.00 | +23.8% | Hold | 10.9x | 11 |
SIGASIGA Technologies, Inc. | $263M | $3.67 | — | — | Buy | 2.2x | 1 |
ESTAEstablishment Labs Holdings Inc. | $2.7B | $91.04 | $76.17 | -16.3% | Buy | — | 14 |
ALGNAlign Technology, Inc. | $13.3B | $185.22 | $203.60 | +9.9% | Buy | 16.3x | 33 |
ISRGIntuitive Surgical, Inc. | $151.3B | $427.30 | $597.78 | +39.9% | Buy | 40.9x | 55 |
Quick answers to the most common questions about buying SY stock.
SY's consensus price target is $0.8, -52.9% below the current price of $1.7. The 5 analysts tracking SY see downside risk at present valuations.
SY has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is predominantly bullish, with 5 Buy/Strong Buy ratings. The consensus 12-month price target of $0.8 implies -52.9% downside from current levels.
SY's current price is $1.7 with a consensus target of $0.8 (-52.9% implied move). Analyst estimates suggest the stock is overvalued at current levels.
The most bullish Wall Street analyst has a price target of $0.8 for SY, while the most conservative target is $0.8. The consensus of $0.8 represents the median expectation. These targets typically reflect 12-month expectations.
SY is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month SY stock forecast based on 5 Wall Street analysts shows a consensus price target of $0.8, with estimates ranging from $0.8 (bear case) to $0.8 (bull case). The median consensus rating is "Buy".
Analysts are cautious on SY, with 0 Sell ratings and a price target of $0.8 (-52.9% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
SY analyst price targets range from $0.8 to $0.8, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $0.8 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.